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Introduction 
The pressure of rising demand on ophthalmic services in the UK, and the negative effect of capacity 
shortfall on clinical outcomes is well attested.1 With the major ophthalmic conditions of public health 
interest, cataract, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy (DR), 
being strongly associated with increasing age, the capacity/demand disequilibrium is expected to 
worsen with an ageing demographic. Epidemiological modelling for The Royal College of 
Ophthalmologists (RCOphth) commissioned Way Forward project predicted that between 2015 and 
2035 the UK will experience a growth in case numbers of 44% for glaucoma, 50% for operable 
cataract and 59% for AMD.2 Published projections suggest that diabetic numbers will also rise by 
~50%.3,4 
Rising prevalence is compounded by expansion of cost-effective but labour-intensive treatment 
options and lower treatment thresholds without a commensurate growth in resources. Human 
resources are a particular problem with a global shortage of ophthalmologists,5 and realisation that 
recruitment of staff from the health systems of countries with far greater ophthalmic human resource 
problems than the UK is no longer ethically acceptable.6 
A paradigm shift is required in the delivery of ophthalmic care to protect patients. The Way Forward 
project was constructed to facilitate shared learning as innovations in service design are identified and 
disseminated. The full reports are available online (www.rcophth.ac.uk/standards-publications-
research/the-way-forward); this article provides a summary of the findings with exemplars. 
Way Forward Methodology 
A literature review was conducted and semi-structured telephone interviews, offered via Lead 
Clinicians, were completed with consultant ophthalmologists responsible for Glaucoma (n=43), 
Cataract (50), Diabetic Retinopathy (36), and AMD (30) from December 2015 - June 2016.  
 
Glaucoma  
Demand management – Typically ~40% of community optometrist referrals for suspected glaucoma 
are false positives7,8 and are amenable to reduction by referral filtering schemes.7-10 Two thirds of 
glaucoma consultants reported such schemes in their locality, so for one third, the opportunity exists 
to, at least, start a repeat measures scheme for intra-ocular pressure (IOP) based referrals. 
 
Pathway redesign – Optimal utilisation of the decision-making ability of senior ophthalmologists for 
complex cases is essential. This is not a new concept with early innovators running modified services 
in the 1990s.11 Stratification of cases by risk permits allocation of low risk cases to either a virtual 
clinic, or a multi-disciplinary team (MDT) clinic, with optometrists/nurse practitioners/orthoptists 
(non-medical health care practitioners (HCPs)) requesting consultant input only as required. Virtual 
clinics involve visual acuity (VA), IOP and visual field data acquisition by HCPs / technicians, often 
also obtaining disc images, pachymetry and even gonioscopy. Consultant review of the data/images is 
then undertaken (typically 10-12 patients reviewed per hour) and letters sent to patients to inform 
them of the outcome. 
 
Task Shifting – Task shifting can be a two-step process.12 Once appropriate complexity patients are 
being managed satisfactorily by MDT in the hospital, the location of this devolved clinical work may 
be shifted into the community; convenient for patients but potentially more expensive.13,14  
 
Cataract 
Demand management – A survey in England showed that 71/151 commissioning bodies explicitly 
ration access to cataract surgery despite poor evidence to guide criteria-setting,15,16 and it being 
contrary to RCOphth guidelines.17 
 
Pathway redesign – Bilateral cataract patients can be treated with just three hospital visits (figure 1); 
safety in this pathway is permitted by easy-access symptom-driven post-operative review, 
autorefraction guiding second eye lens selection. A less radical change, well established in many units 
is to discharge uncomplicated second-eye cataract patients from theatre. This is an easy win capacity 
reduction, but refractive outcome data collection must be monitored. 
 
Task Shifting - Nine out of ten departments still routinely reviewing post-operative cataract patients 
use non-ophthalmologists. More difficult to replicate perhaps is the one in five departments who has 
trained HCPs seeing cataract referrals; ophthalmologists only see the patient for surgery. This 
pathway relies on high-quality MDT members and does not adhere to current RCOphth guidelines. 
 
Efficient surgical service delivery –Despite the recommendation from RCOphth and Monitor that 
one cataract operation is done every 30 minutes,18 the mode number of cases reported at interview 
was 6 on 4 hour lists both for training and consultant-only lists. However, 5 departments routinely 
scheduled ≥10 cases. The expense of anaesthetists can be saved on dedicated local anaesthetic lists 
provided staff have appropriate life support training. 
 
AMD 
Demand management – Referral refinement was not a perceived need, but two thirds of departments 
run virtual AMD clinics (VA/OCT/photo), and for some this is their standard initial evaluation for all 
new referrals to minimise delays for high-risk cases, and discharge of false-positive referrals. 
Pathway redesign – AMD pathways are in a state of evolution nationally.19 Almost one third of 
departments offer one-stop assessment/injection for first visits, and almost half do for follow-ups. 
Task shifting – Virtual clinics can be quality assured, hence many consultants pass on the virtual 
review work to trained HCPs. Non-ophthalmologist injection services are commonplace, however 
over one third of departments still have all injections given by ophthalmologists.20 
 
Diabetic Retinopathy 
Demand management – Repeated local audits showed more than 50% of new DR referrals were for 
maculopathy that did not require intervention.21 Half of the consultants interviewed had virtual review 
clinics for maculopathy, and in some cases the screening programme itself has taken on this work.22 
Screeners time can be freed up by automated computer disease/no disease grading removing 30% of 
images from their workload.23 
 
Task shifting – As well as referral refinement, the pool of experienced DR screening graders can be 
utilised for monitoring treated proliferative disease.24 
 
Pathway redesign – Capacity wastage from failure to attend (DNA) must be minimised using the 
evidence based interventions that exist (Figure 2).25 
Discussion 
The Way Forward project has given some sense of the scale of the future demand facing UK eye 
departments, and some of the options already in use by colleagues around the country. Inaction is not 
an option. It is incumbent on each department in the UK to identify opportunities for service redesign 
to maximise efficiency and reduce unwarranted variation. Tasks that can be safely devolved to trained 
HCPs, or areas where technology may offer time savings should also be explored, such that senior 
ophthalmologists are fully engaged in activities which genuinely require the training, knowledge and 
experience that they have and so that every MDT member, the ophthalmologist included, is operating 
at the top of their grade. 
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Figure 1: The lightest cataract pathway involved no routine review after 1st or 2nd eye 
 
Figure 2: Strategic intentional demand-capacity management is essential 
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